Authors:
CARLILE DJ
STEVENS AJ
ASHFORTH EIL
WAGHELA D
HOUSTON JB
Citation: Dj. Carlile et al., IN-VIVO CLEARANCE OF ETHOXYCOUMARIN AND ITS PREDICTION FROM IN-VITRO SYSTEMS - USE OF DRUG DEPLETION AND METABOLITE FORMATION METHODS IN HEPATIC MICROSOMES AND ISOLATED HEPATOCYTES, Drug metabolism and disposition, 26(3), 1998, pp. 216-221
Citation: Jb. Houston et Dj. Carlile, INCORPORATION OF IN-VITRO DRUG-METABOLISM DATA INTO PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELS, Toxicology in vitro, 11(5), 1997, pp. 473-478
Citation: Jb. Houston et Dj. Carlile, PREDICTION OF HEPATIC-CLEARANCE FROM MICROSOMES, HEPATOCYTES, AND LIVER SLICES, Drug metabolism reviews, 29(4), 1997, pp. 891-922
Citation: Dj. Carlile et al., SCALING FACTORS TO RELATE DRUG METABOLIC-CLEARANCE IN HEPATIC MICROSOMES, ISOLATED HEPATOCYTES, AND THE INTACT LIVER - STUDIES WITH INDUCEDLIVERS INVOLVING DIAZEPAM, Drug metabolism and disposition, 25(8), 1997, pp. 903-911
Authors:
BACH PH
VICKERS AEM
FISHER R
BAUMANN A
BRITTEBO E
CARLILE DJ
KOSTER HJ
LAKE BG
SALMON F
SAWYER TW
SKIBINSKI G
Citation: Ph. Bach et al., THE USE OF TISSUE-SLICES FOR PHARMACOTOXICOLOGY STUDIES - THE REPORT AND RECOMMENDATIONS OF ECVAM-WORKSHOP-20, ATLA. Alternatives to laboratory animals, 24(6), 1996, pp. 893-923
Citation: K. Zomorodi et al., KINETICS OF DIAZEPAM METABOLISM IN RAT HEPATIC MICROSOMES AND HEPATOCYTES AND THEIR USE IN PREDICTING IN-VIVO HEPATIC-CLEARANCE, Xenobiotica, 25(9), 1995, pp. 907-916
Authors:
ASHFORTH EIL
CARLILE DJ
CHENERY R
HOUSTON JB
Citation: Eil. Ashforth et al., PREDICTION OF IN-VIVO DISPOSITION FROM IN-VITRO SYSTEMS - CLEARANCE OF PHENYTOIN AND TOLBUTAMIDE USING RAT HEPATIC-MICROSOMAL AND HEPATOCYTE DATA, The Journal of pharmacology and experimental therapeutics, 274(2), 1995, pp. 761-766